{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:21:17Z","timestamp":1782919277761,"version":"3.54.5"},"reference-count":105,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>This review aimed to identify and synthesize strategies and actions adopted by addiction facilities to support and maintain treatment during the coronavirus disease 2019 (COVID-19) pandemic. A scoping review was conducted using the following information sources: Virtual Health Library, SCOPUS, Web of Science, PubMed, CINAHL, and Latin American and Caribbean Health Science Literature. From a total of 971 articles, 28 studies were included. The strategies to maintain the care offer were telehealth\/telemedicine, counselling\/screening, 24-h telephone, webinars, conducting group therapy and support among users, adaptation for electronic health records, increased methadone\/naloxone dispensing, restriction in the number of medication dispensing\/day, and electronic prescription and home delivery medications. These strategies can be used to support health professionals in addressing the impact of the pandemic on the treatment of those in recovery or struggling with a substance use disorder when in-person treatment is not possible.<\/jats:p>","DOI":"10.3390\/ijerph182212094","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T08:53:56Z","timestamp":1637225636000},"page":"12094","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Strategies Adopted by Addiction Facilities during the Coronavirus Pandemic to Support Treatment for Individuals in Recovery or Struggling with a Substance Use Disorder: A Scoping Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3140-8394","authenticated-orcid":false,"given":"Divane","family":"de Vargas","sequence":"first","affiliation":[{"name":"School of Nursing, S\u00e3o Paulo University, S\u00e3o Paulo 05403-000, Brazil"},{"name":"Nucleon of Addiction Nursing Research, School of Nursing (NEPEEA), University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-8753","authenticated-orcid":false,"given":"Caroline Figueira","family":"Pereira","sequence":"additional","affiliation":[{"name":"School of Nursing, S\u00e3o Paulo University, S\u00e3o Paulo 05403-000, Brazil"},{"name":"Nucleon of Addiction Nursing Research, School of Nursing (NEPEEA), University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5709-7008","authenticated-orcid":false,"given":"Rosa Jacinto","family":"Volpato","sequence":"additional","affiliation":[{"name":"School of Nursing, S\u00e3o Paulo University, S\u00e3o Paulo 05403-000, Brazil"},{"name":"Nucleon of Addiction Nursing Research, School of Nursing (NEPEEA), University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-9656","authenticated-orcid":false,"given":"Ana Vit\u00f3ria Corr\u00eaa","family":"Lima","sequence":"additional","affiliation":[{"name":"School of Nursing, S\u00e3o Paulo University, S\u00e3o Paulo 05403-000, Brazil"},{"name":"Nucleon of Addiction Nursing Research, School of Nursing (NEPEEA), University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rog\u00e9rio","family":"da Silva Ferreira","sequence":"additional","affiliation":[{"name":"Nucleon of Addiction Nursing Research, School of Nursing (NEPEEA), University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4405-5199","authenticated-orcid":false,"given":"Sheila Ramos","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"School of Nursing, S\u00e3o Paulo University, S\u00e3o Paulo 05403-000, Brazil"},{"name":"Nucleon of Addiction Nursing Research, School of Nursing (NEPEEA), University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Faustino","family":"Aguilar","sequence":"additional","affiliation":[{"name":"School of Nursing, S\u00e3o Paulo University, S\u00e3o Paulo 05403-000, Brazil"},{"name":"Nucleon of Addiction Nursing Research, School of Nursing (NEPEEA), University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2021, August 21). Timeline: WHO\u2019s COVID-19 Response. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/interactive-timeline?gclid=CjwKCAjwyIKJBhBPEiwAu7zll5MLHIC7uevWiLON1zSfTgmtnOJUgnyKNqPK2n78ax0UvxkCChAFZRoCSjsQAvD_BwE#!."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2021, August 21). Director-Gernal\u2019s Opening Remarks at the Media Briefing on COVID-19. Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-Covid-19---11-march-2020."},{"key":"ref_3","first-page":"14","article-title":"Mental health interventions following COVID-19 and other coronavirus infections: A systematic review of current recommendations and meta-analysis of randomized controlled trials","volume":"1","author":"Damiano","year":"2021","journal-title":"Braz. J. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S2215-0366(20)30168-1","article-title":"Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science","volume":"7","author":"Holmes","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2020.04.028","article-title":"A longitudinal study on the mental health of general population during the COVID-19 epidemic in China","volume":"87","author":"Wang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_6","unstructured":"Matta, G.C., Rego, S., Souto, E.P., and Segata, J. (2021). COVID-19 in Brazil and the Various Faces of the Pandemic: Presentation. COVID-19\u2019s Social Impacts in Brazil: Vulnerable Populations and Responses to the Pandemic, Fiocruz."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wei, Y., and Shah, R. (2020). Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications. Pharmaceuticals, 13.","DOI":"10.20944\/preprints202007.0061.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2215-0366(20)30144-9","article-title":"Public health messaging and harm reduction in the time of COVID-19","volume":"7","author":"Karamouzian","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_9","unstructured":"Organiza\u00e7\u00e3o Pan-Americana da Sa\u00fade (OPAS) (2021, August 21). Response to the COVID-19 Pandemic in the Americas: Response Strategy and Call to Donors January-December 2021. Available online: https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/54425\/OPASPHEHEOCOVID19210008_por.pdf?sequence=1&isAllowed=y."},{"key":"ref_10","unstructured":"Hirdes, A., Marcon, G., Branchi, R.N., and Vivian, A.G. (2015). Prevention of Alcohol and Other Drugs Use and Treatment in Primary Health Care in a Southern Brazilian City. Aletheia, 74\u201389. Available online: http:\/\/pepsic.bvsalud.org\/scielo.php?script=sci_arttext&pid=S1413-03942015000100007&lng=pt&tlng=."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/YCO.0000000000000351","article-title":"Stigma and substance use disorders: An international phenomenon","volume":"30","author":"Yang","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08897077.2020.1784363","article-title":"COVID-19 and persons with substance use disorders: Inequities and mitigation strategies","volume":"41","author":"Melamed","year":"2020","journal-title":"Subst. Abus."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/M20-1212","article-title":"Collision of the COVID-19 and Addiction Epidemics","volume":"173","author":"Volkow","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: Towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol. Theory Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Int. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"108094","DOI":"10.1016\/j.jsat.2020.108094","article-title":"Sheltering in place and social distancing when the services provided are housing and social support: The COVID-19 health crisis and recovery housing","volume":"119","author":"Mericle","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"575755","DOI":"10.3389\/fpsyt.2020.575755","article-title":"The Impact of COVID-19 Pandemic on the Castile and Leon Addiction Treatment Network: A Real-Word Experience","volume":"11","author":"Roncero","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12954-020-00432-w","article-title":"The impact of the COVID-19 pandemic on harm reduction services in Spain","volume":"17","author":"Picchio","year":"2020","journal-title":"Harm. Reduct. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108124","DOI":"10.1016\/j.jsat.2020.108124","article-title":"Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine","volume":"118","author":"Sousa","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/ADM.0000000000000685","article-title":"Innovation During COVID-19: Improving Addiction Treatment Access","volume":"14","author":"Samuels","year":"2020","journal-title":"J. Addict. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"108103","DOI":"10.1016\/j.jsat.2020.108103","article-title":"Integrating harm reduction and clinical care: Lessons from COVID-19 respite and recuperation facilities","volume":"118","author":"Kimmel","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102830","DOI":"10.1016\/j.drugpo.2020.102830","article-title":"Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders","volume":"83","author":"Rosca","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1097\/ADM.0000000000000682","article-title":"Low Barrier Tele-Buprenorphine in the Time of COVID-19: A case report","volume":"14","author":"Harris","year":"2020","journal-title":"J. Addict. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/ADM.0000000000000684","article-title":"Opioid Use Disorder and COVID-19: Crashing of the Crises","volume":"14","author":"Khatri","year":"2020","journal-title":"J. Addict. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"108181","DOI":"10.1016\/j.jsat.2020.108181","article-title":"COVID-19 innovations in medication for addiction treatment at a Skid Row syringe exchange","volume":"121","author":"Tringale","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"113047","DOI":"10.1016\/j.psychres.2020.113047","article-title":"COVID19 pandemic and people with opioid use disorder: Innovation to reduce risk","volume":"289","author":"Vecchio","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-020-00438-4","article-title":"Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic","volume":"17","author":"Castillo","year":"2020","journal-title":"Harm Reduct. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4103\/psychiatry.IndianJPsychiatry_1044_20","article-title":"Organization of mental healthcare in Bosnia and Herzegovina during coronavirus disease 2019 pandemic","volume":"62","author":"Pajevic","year":"2020","journal-title":"Indian J. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"108219","DOI":"10.1016\/j.jsat.2020.108219","article-title":"Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19","volume":"122","author":"Joseph","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12954-020-00394-z","article-title":"A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: A report","volume":"17","author":"Crowley","year":"2020","journal-title":"Harm Reduct. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jrh.12438","article-title":"A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder","volume":"37","author":"Wilson","year":"2020","journal-title":"J. Rural. Health"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"MacKinnon, L., Soc\u00edas, M.E., and Bardwell, G. (2020). COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings. J. Subst. Abuse Treat., 108153.","DOI":"10.1016\/j.jsat.2020.108153"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108276","DOI":"10.1016\/j.jsat.2021.108276","article-title":"Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19","volume":"123","author":"Figgatt","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108215","DOI":"10.1016\/j.jsat.2020.108215","article-title":"Telehealth sustains patient engagement in OUD treatment during COVID-19","volume":"122","author":"Langabeer","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"108163","DOI":"10.1016\/j.jsat.2020.108163","article-title":"The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19","volume":"120","author":"Hughto","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"108220","DOI":"10.1016\/j.jsat.2020.108220","article-title":"With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic","volume":"122","author":"Courser","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102582","DOI":"10.1016\/j.ajp.2021.102582","article-title":"Telemedicine-assisted stepwise approach of service delivery for substance use disorders in India","volume":"58","author":"Ghosh","year":"2021","journal-title":"Asian J. Psychiatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"108270","DOI":"10.1016\/j.jsat.2020.108270","article-title":"Substance use treatment in Appalachian Tennessee amid COVID-19: Challenges and preparing for the future","volume":"124","author":"Kedia","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_39","first-page":"16","article-title":"Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: A case study","volume":"16","author":"MacDonald","year":"2021","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13722-021-00221-1","article-title":"Adapting inpatient addiction medicine consult services during the COVID-19 pandemic","volume":"16","author":"Harris","year":"2021","journal-title":"Addict. Sci. Clin. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hanton, K., McHugh, D., and Boris, G. (2021). A Case Series: Successfully Preventing COVID-19 Outbreak in a Residential Community Setting at a Drug and Alcohol Addiction Treatment Center. Healthcare, 9.","DOI":"10.3390\/healthcare9010088"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0033354921999396","article-title":"Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach","volume":"136","author":"Noyes","year":"2021","journal-title":"Public Health Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"108255","DOI":"10.1016\/j.jsat.2020.108255","article-title":"Impacts of COVID-19 on residential treatment programs for substance use disorder","volume":"123","author":"Pagano","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_44","unstructured":"Aromataris, E., and Munn, Z. (2020). JBI Manual for Evidence Synthesis, JBI."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1475-9276-12-18","article-title":"Patient-centred access to health care: Conceptualising access at the interface of health systems and populations","volume":"12","author":"Levesque","year":"2013","journal-title":"Int. J. Equity Health"},{"key":"ref_46","unstructured":"Substance Abuse and Mental Health Services Administration (2006). Addressing Diverse Populations in Intensive Outpatient Treatment, Substance Abuse: Clinical Issues in Intensive Outpatient Treatment."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/add.15080","article-title":"Mitigating and learning from the impact of COVID-19 infection on addictive disorders","volume":"115","author":"Marsden","year":"2020","journal-title":"Addiction"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1590\/1806-9282.66.10.1320","article-title":"Telehealth actions in times of COVID-19: Information with evidence","volume":"66","author":"Freire","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1176\/appi.ps.202000250","article-title":"Suddenly becoming a \u201cvirtual doctor\u201d: Experiences of psychiatrists transitioning to telemedicine during the COVID-19 pandemic","volume":"71","author":"Sousa","year":"2020","journal-title":"Psychiatr. Serv."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/YCO.0000000000000708","article-title":"Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic","volume":"34","author":"Li","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e25541","DOI":"10.2196\/25541","article-title":"Transitioning to remote clinic visits in a smoking cessation trial during the SARS coronavirus-2 pandemic: Mixed methods evaluation","volume":"5","author":"Mahoney","year":"2021","journal-title":"JMIR Form. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.mayocp.2020.10.011","article-title":"Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook","volume":"95","author":"Oesterle","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/ADM.0000000000000678","article-title":"Optimizing medication treatment of opioid use disorder during COVID-19 (SARS-CoV-2)","volume":"14","author":"Leppla","year":"2020","journal-title":"J. Addict. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/SAR.S81535","article-title":"Benefits of peer support groups in the treatment of addiction","volume":"7","author":"Tracy","year":"2016","journal-title":"Subst. Abuse Rehabil."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14659891.2019.1677794","article-title":"Peer support workers in substance abuse treatment services: A systematic review of the literature","volume":"25","author":"Whitaker","year":"2020","journal-title":"J. Subst. Use"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"576421","DOI":"10.3389\/frvir.2020.576421","article-title":"Therapists Make the Switch to Telepsychology to Safely Continue Treating their Patients during the COVID-19 Pandemic. Virtual Reality Telepsychology May Be Next","volume":"1","author":"Sampaio","year":"2021","journal-title":"Front. Virtual Real."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/anae.15185","article-title":"Education and scientific dissemination during the COVID-19 pandemic","volume":"76","author":"Fawcett","year":"2020","journal-title":"Anaesthesia"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ismail, I.I., Abdelkarim, A., and Al-Hashel, J.Y. (2021). Physicians\u2019 attitude towards webinars and online education amid COVID-19 pandemic: When less is more. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0250241"},{"key":"ref_59","unstructured":"The American Osteopathic Academ of Addiction Medicine (AOAAM) (2021, September 18). Webinar Series: Education, Buprenorphine Induction for High Potency Synthetic Opioid Users. Aoaam.Org, Available online: https:\/\/education.aoaam.org\/products\/buprenorphine-induction-for-high-potency-synthetic-opioid-users."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Graig, L., Friedman, K., and Alper, J. (2020). Caring for People with Mentl Health and Substance Use Disorders in Primary Care Settings: Proceeding of Workshop, The National Academies Press.","DOI":"10.17226\/25927"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/tmj.2020.0201","article-title":"Applications of e-Health to support person-centered health care at the time of COVID-19 Pandemic","volume":"27","author":"Tebeje","year":"2021","journal-title":"Telemed. J. E Health"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e28497","DOI":"10.2196\/28497","article-title":"Using Electronic Health Records to Mitigate Workplace Burnout Among Clinicians During the COVID-19 Pandemic: Field Study in Iran","volume":"9","author":"Esmaeilzadeh","year":"2021","journal-title":"JMIR Med. Inform."},{"key":"ref_63","unstructured":"Department of Health and Social Care and Public Health England (2021, October 21). COVID-19: Guidance for Commissioners and Providers of Services for People Who Use Drugs or Alcohol, Available online: https:\/\/www.gov.uk\/government\/publications\/Covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol\/Covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol."},{"key":"ref_64","unstructured":"Substance Abuse and Mental Health Services Administration (2020). FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency."},{"key":"ref_65","unstructured":"Substance Abuse and Mental Health Services Administration (2015). Federal Guidelines for Opioid Treatment Programs Retrieved from Rockville."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.15585\/mmwr.mm7010a3","article-title":"Notes from the Field: Opioid Overdose Deaths before, during, and after an 11-Week COVID-19 Stay-at-Home Order\u2014Cook County, Illinois, January 1 2018\u2013October 6 2020","volume":"70","author":"Mason","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Moustaqim-Barrette, A., Papamihali, K., Mamdani, Z., Williams, S., and Buxton, J.A. (2020). Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238618"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"108197","DOI":"10.1016\/j.jsat.2020.108197","article-title":"Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the COVID-19 pandemic","volume":"121","author":"Dunn","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/add.15181","article-title":"A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder","volume":"116","author":"Fishman","year":"2021","journal-title":"Addiction"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/SAR.S69715","article-title":"Primary care for opioid use disorder","volume":"7","author":"Mannelli","year":"2016","journal-title":"Subst. Abuse Rehabil."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lagisetty, P., Klasa, K., Bush, C., Heisler, M., Chopra, V., and Bohnert, A. (2017). Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186315"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/1533256X.2020.1793064","article-title":"Substance use disorders and COVID-19: The role of telehealth in treatment and research","volume":"20","author":"Kleykamp","year":"2020","journal-title":"J. Soc. Work Pract. Addict."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"108226","DOI":"10.1016\/j.jsat.2020.108226","article-title":"Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response","volume":"124","author":"McDonnell","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_74","unstructured":"World Health Organization (WHO) (2021, October 21). COVID-19 Disrupting Mental Health Services in Most Countries. Available online: https:\/\/www.who.int\/news\/item\/05-10-2020-Covid-19-disrupting-mental-health-services-in-most-countries-who-survey."},{"key":"ref_75","first-page":"1178221819833379","article-title":"How social relation-ships influence substance use disorder recovery: A collaborative narrative study","volume":"13","author":"Pettersen","year":"2019","journal-title":"Subst. Abuse"},{"key":"ref_76","first-page":"107","article-title":"Institutionalizing the Centers for Disease Control and Prevention\u2019s Independence","volume":"12","author":"Reiss","year":"2020","journal-title":"ConLawNOW"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/joms.12644","article-title":"15 Days to Slow the Spread: COVID-19 and Collective Resilience","volume":"58","author":"Glynn","year":"2021","journal-title":"J. Manag. Stud."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.35946\/arcr.v41.1.04","article-title":"The Emergence, Role, and Impact of Recovery Support Services","volume":"41","author":"Jason","year":"2021","journal-title":"Alcohol Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1590\/1413-81232020259.17812020","article-title":"Challenges and proposals for scaling up COVID-19 testing and diagnosis in Brazil","volume":"25","author":"Magno","year":"2020","journal-title":"Cien Saude Colet."},{"key":"ref_80","unstructured":"Priest, K.C. (2021). The COVID-19 pandemic: Practice and policy considerations for patients with opioid use disorder. Health Affairs Blog, 10."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1176\/appi.ajp.2021.20101548","article-title":"Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review","volume":"178","author":"McCarty","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.jsat.2021.108393","article-title":"The new services that opioid treatment programs have adopted in response to COVID-19","volume":"130","author":"Cantor","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/10482911211029580","article-title":"Confronting Two Crises: The COVID-19 Pandemic, the Opioid Epidemic, and the Industrial Hygienist","volume":"31","author":"Rosen","year":"2021","journal-title":"New Solut."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.sapharm.2020.11.017","article-title":"Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries","volume":"17","author":"Paudyal","year":"2021","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"103076","DOI":"10.1016\/j.drugpo.2020.103076","article-title":"Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19","volume":"90","author":"Olding","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"102986","DOI":"10.1016\/j.drugpo.2020.102986","article-title":"Understanding challenges for recovery homes during COVID-19","volume":"93","author":"Polcin","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.2020.20040417","article-title":"New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol and Substance Use Disorders-The Perfect Storm","volume":"177","author":"Spagnolo","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"653674","DOI":"10.3389\/fpsyt.2021.653674","article-title":"Substance Use Disorders and Behavioral Addictions During the COVID-19 Pandemic and COVID-19-Related Restrictions","volume":"12","author":"Avena","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1590\/1413-81232020256.1.10502020","article-title":"Social distancing measures to control the COVID-19 pandemic: Potential impacts and challenges in Brazil","volume":"25","author":"Aquino","year":"2020","journal-title":"Cien Saude Colet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e20200106","DOI":"10.1590\/1980-265x-tce-2020-0106","article-title":"What has the Covid-19 pandemic taught us about adopting preventive measures?","volume":"29","author":"Oliveira","year":"2020","journal-title":"Texto Contexto-Enferm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugpo.2019.06.018","article-title":"\u201cWe don\u2019t got that kind of time, man. We\u2019re trying to get high!\u201d: Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs","volume":"71","author":"Bardwell","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ACM.0000000000001294","article-title":"Structural Vulnerability: Operationalizing the Concept to Address Health Disparities in Clinical Care","volume":"92","author":"Bourgois","year":"2017","journal-title":"Acad. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/pubmed\/fdaa181","article-title":"Clinical impact of COVID-19 on people with substance use disorders","volume":"43","author":"Vallecillo","year":"2021","journal-title":"J. Public Health"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Babor, T.F. (2021). Treatment systems for population management of substance use disorders: Requirements and priorities from a public health perspective. Textbook of Addiction Treatment, Springer.","DOI":"10.1007\/978-3-030-36391-8_39"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14295\/jmphc.v12.1000","article-title":"Relationship between Psychoactive Drug Consumption and COVID-19: Synthesis of evidence","volume":"12","author":"Barbosa","year":"2020","journal-title":"J. Manag. Prim. Health Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/adb.12543","article-title":"Young alcohol binge drinkers have elevated blood endotoxin, peripheral inflammation and low cortisol levels: Neuropsychological correlations in women","volume":"23","author":"Orio","year":"2018","journal-title":"Addict. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1001\/archinte.164.20.2206","article-title":"Cigarette Smoking and Infection","volume":"164","author":"Arcavi","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.rmr.2019.11.641","article-title":"Pulmonary complications in cocaine users","volume":"37","author":"Underner","year":"2020","journal-title":"Rev. Mal. Respir."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e195172","DOI":"10.1001\/jamanetworkopen.2019.5172","article-title":"Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_100","unstructured":"(2020). World Drug Report 2020. Drug Use and Health Consequences, United Nations Publication."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-8261-4","article-title":"Suicide among people treated for drug use disorders: A Danish national record-linkage study","volume":"20","author":"Hesse","year":"2020","journal-title":"BMC Public Health"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1590\/0034-7167-2018-0760","article-title":"Multidisciplinary team actions of a Brazilian Psychosocial Care Center for Alcohol and Drugs","volume":"72","author":"Lopes","year":"2019","journal-title":"Rev. Bras. Enferm."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e053185","DOI":"10.1136\/bmjopen-2021-053185","article-title":"Barriers and facilitators to accessing health and social care services for people living in homeless hostels: A qualitative study of the experiences of hostel staff and residents in UK hostels","volume":"11","author":"Armstrong","year":"2021","journal-title":"BMJ Open"},{"key":"ref_105","unstructured":"World Health Organization (WHO) (2021, October 27). Global Status Report on Alcohol and Health 2018. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/274603."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/22\/12094\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:32:02Z","timestamp":1760167922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/22\/12094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":105,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijerph182212094"],"URL":"https:\/\/doi.org\/10.3390\/ijerph182212094","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]}}}